Northern NTRSO Q1 2026 Beat Revenue NA EPS Exceeds by Significant Whitehawk Therapeutics WHWK Climbs 369 Resistance at 443 in Focus 20260520 NFL Seeks to Curb Certain Prediction Market Contracts Citing Integrity Concerns Whats Next for National NHPAP at 2235 20260520 Spyre Therapeutics SYRE Stock Analysis Climbs 796 Eyes on 7552 20260520 Chewy CHWY Up 407 Is There More Room to Run 20260520 Runway RWAYI Unchanged at 2444 RangeBound Trading 20260520